Cognitive function and nigrostriatal markers in abstinent methamphetamine abusers. - Wikidata - awgldk - TriplyDB

Cognitive function and nigrostriatal markers in abstinent methamphetamine abusers.

Cognitive function and nigrostriatal markers in abstinent methamphetamine abusers.

http://www.wikidata.org/entity/Q46976616

about

Is cognitive functioning impaired in methamphetamine users? A critical review Neurologic manifestations of chronic methamphetamine abuse Neuropsychological Consequences of Chronic Drug Use: Relevance to Treatment Approaches Are executive function and impulsivity antipodes? A conceptual reconstruction with special reference to addiction Pharmacotherapy for stimulant-related disorders An evaluation of the evidence that methamphetamine abuse causes cognitive decline in humans.Neuroimaging for drug addiction and related behaviors The neurocircuitry of illicit psychostimulant addiction: acute and chronic effects in humans Recent advances in methamphetamine neurotoxicity mechanisms and its molecular pathophysiology Methamphetamine self-administration is associated with persistent biochemical alterations in striatal and cortical dopaminergic terminals in the rat Striatal Dopamine D2/D3 Receptor Availability Is Associated with Executive Function in Healthy Controls but Not Methamphetamine Users Pharmacotherapeutic agents in the treatment of methamphetamine dependence.Neonatal +-methamphetamine exposure in rats alters adult locomotor responses to dopamine D1 and D2 agonists and to a glutamate NMDA receptor antagonist, but not to serotonin agonists.Monoamine transporter inhibitors and substrates as treatments for stimulant abuse Neurotoxicity of methamphetamine and 3,4-methylenedioxymethamphetamine Imaging addiction: D2 receptors and dopamine signaling in the striatum as biomarkers for impulsivity Effect of a neurotoxic dose regimen of (+)-methamphetamine on behavior, plasma corticosterone, and brain monoamines in adult C57BL/6 mice.Functional and structural brain changes associated with methamphetamine abuse Chronic methamphetamine abuse and corticostriatal deficits revealed by neuroimaging.Alterations in the striatal dopamine system during intravenous methamphetamine exposure: effects of contingent and noncontingent administration.Mesocorticolimbic monoamine correlates of methamphetamine sensitization and motivation.Methamphetamine use parameters do not predict neuropsychological impairment in currently abstinent dependent adults.Effect of methamphetamine dependence on everyday functional ability Striatal volume increases in active methamphetamine-dependent individuals and correlation with cognitive performance Methamphetamine dependence and neuropsychological functioning: evaluating change during early abstinence Biological substrates of addiction.Environmental enrichment reduces methamphetamine cue-induced reinstatement but does not alter methamphetamine reward or VMAT2 function.Cocaine abuse in humans is not associated with increased microglial activation: an 18-kDa translocator protein positron emission tomography imaging study with [11C]PBR28.Longer term improvement in neurocognitive functioning and affective distress among methamphetamine users who achieve stable abstinence.Neuropsychological deficits in adolescent methamphetamine abusers.A randomized, placebo-controlled trial of sustained-release dextroamphetamine for treatment of methamphetamine addiction.Methamphetamine: an update on epidemiology, pharmacology, clinical phenomenology, and treatment literature Regulation of the Dopamine and Vesicular Monoamine Transporters: Pharmacological Targets and Implications for Disease.Degree of dependence influences the effect of smoking on cognitive flexibility Effect of methamphetamine dependence on inhibitory deficits in a novel human open-field paradigm Mitochondria: key players in the neurotoxic effects of amphetamines.Mouse strain- and age-dependent effects of binge methamphetamine on dopaminergic signaling Cortical ionotropic glutamate receptor antagonism protects against methamphetamine-induced striatal neurotoxicity.Methamphetamine self-administration causes persistent striatal dopaminergic alterations and mitigates the deficits caused by a subsequent methamphetamine exposure.Acute, low-dose methamphetamine administration improves attention/information processing speed and working memory in methamphetamine-dependent individuals displaying poorer cognitive performance at baseline.

P2860

Q24606455-2CAE1825-C926-4F6A-9E9E-7EEB49AE734E Q24624506-73DBC1F0-0BC9-437A-9EA6-8D31559CAE9A Q26772775-8F7385A3-20B3-4BF2-9E54-CE9386F79506 Q26824038-44182283-2FD6-4681-B33A-94B78DFFF2B4 Q26829186-33AF19FD-A780-491C-A879-624590C7D20D Q26866314-0465782C-8EC5-4239-8556-CEBF2527FB4C Q27014859-F5D3D914-AE6E-4CCD-8AFD-54ABDA7F41AC Q28236333-DF77777C-EBE0-4E01-A403-725139CDBCCA Q28260273-64BD947A-48E6-445C-8417-5799BE7AEC74 Q28472559-9F73CEDC-F8AD-4185-8FB2-6641DE051B7E Q28551943-568AFA8F-64C5-4C58-A832-359B4D285AD5 Q30235058-D377291A-F34A-41C8-9502-42756D04145B Q30401457-28CCB6F3-D1A0-4345-954B-FA0D8587A958 Q30413718-2762C21C-EED3-4F71-A3BD-81B3A350E1F1 Q30417935-578F9A94-7BE8-4E57-9C6F-12180DE14C7F Q30422045-051B1B4B-FE96-4AC2-815B-C4C694F66A94 Q30475706-379149B4-DDB3-4DE0-A773-2E5D21510734 Q30833169-B88B1C0D-23F7-449B-8882-8E1BE4816CBF Q30873118-3CD7CC46-AAE4-4940-8019-DCA7BFD54F49 Q33602644-C4C9DCBF-4A7B-4DB6-ACEC-127B53A1D466 Q33605970-D8710F33-60E0-4FBC-9C43-BA53C4F2E71E Q33624189-0AD56EF0-3964-4C64-8BE5-65060A973B9E Q33729520-A8D109FC-5C15-4270-8E27-9F700B1D4607 Q33772001-F150F5A7-D320-4378-8DDC-75545CFC2AE9 Q33810923-688C8F33-8D70-4247-AEBD-B08C55E2AE41 Q33835356-5EC2ADE8-87E1-4D76-8877-16538B142454 Q33896925-B29457BD-9DDB-48FC-A0B4-DD2FA66F7BE0 Q33936013-4B1A8041-934F-4AB8-8B1F-6120CF7633A6 Q34026010-C4043C04-80E9-483A-9B9D-1597EFD2FAA1 Q34126453-202D42E1-E448-45E1-930B-04718759435D Q34156209-B9226CBF-9B57-44D7-BED9-124D5A03A5C4 Q34181746-DC91F614-BD46-413A-964B-C0D787AAB0D9 Q34673305-224CB9A8-6DAA-4988-B8F5-D971E4E9B17A Q34804419-B90A45FF-800D-404A-A272-A9FEBA64A1BC Q35007722-071B5060-D283-4E7B-B653-A99EDC628DF1 Q35572468-C0C44FE1-14FF-4DE7-AB6F-06E1547AC9AD Q35609659-4410A196-F51D-4F36-ADD4-2684E03C80C7 Q35613044-680D577B-E6E5-44BF-A4B7-8F379DA3971B Q35688532-64FBB9B9-5565-4277-B51F-64E7C6AFE7E5 Q35927304-F1833773-2AFE-4340-AE6A-6F37B23E6F3A

P2860

Cognitive function and nigrostriatal markers in abstinent methamphetamine abusers.

http://www.wikidata.org/entity/Q46976616

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh-hant

name

Cognitive function and nigrostriatal markers in abstinent methamphetamine abusers.

@en

Cognitive function and nigrostriatal markers in abstinent methamphetamine abusers.

@nl

type

label

Cognitive function and nigrostriatal markers in abstinent methamphetamine abusers.

@en

Cognitive function and nigrostriatal markers in abstinent methamphetamine abusers.

@nl

prefLabel

Cognitive function and nigrostriatal markers in abstinent methamphetamine abusers.

@en

Cognitive function and nigrostriatal markers in abstinent methamphetamine abusers.

@nl

P1433

Q46976616-1D86C820-A58F-43DF-B957-DC6E4661CA22

P1476

Q46976616-1556F336-3FEB-46A9-91EE-B9439D11B555

P2093

Q46976616-0F5B339A-EC91-4B96-BD67-3318BE13C15B

Q46976616-29BBE259-DDB8-45F1-947C-57B29D611E95

Q46976616-471F31D5-2C3C-44D1-AAD7-56DAD7BEABF1

Q46976616-53F94314-582F-42A3-A69D-FE0603277760

Q46976616-68DE1173-AA0F-490E-887D-188B317CC1CF

Q46976616-91D06B40-0A64-4FB7-8CB0-CDCE0ECC1C0E

Q46976616-B8F2B567-9AAC-44D8-B97B-8BAF34AB8E9D

Q46976616-BCC1C447-58F2-4B75-8628-82BF0E533335

Q46976616-E1F50BD6-C5A2-4FE7-AA52-9707CDBDA39A

Q46976616-FD459658-4C32-486D-966E-8B890F08489D

P2860

Q46976616-2E09E91D-BE88-41CB-AF3D-DE01740FD646

Q46976616-C750435F-EEAD-4011-98A9-B7133B490D04

Q46976616-D40612CE-7843-4B1F-8068-525CF3037E4E

P2888

Q46976616-0E2A3D88-0691-4312-8AD2-876C6F2D4DAA

P304

Q46976616-D4BB8C2F-9297-4606-BEDE-7E68F5E0B281

P31

Q46976616-DD0BE14E-A46C-476E-9D76-A66F17409349

P356

Q46976616-0A168026-7FE9-4EB1-8E90-04D78685BE74

P433

Q46976616-757D4198-CDCC-430D-97E6-C98EF6611C05

P478

Q46976616-10F411DC-595E-4F29-A794-1A810E5AAF5B

P50

Q46976616-FE260F40-2C16-4839-A0FE-7FFC7E45C32B

P577

Q46976616-0563AFA5-9704-4844-8740-DD33BD872A33

P698

Q46976616-B4AB3A80-B353-490B-8B13-1C687CD3B986

P356

S00213-006-0330-6

P1433

Psychopharmacology

P1476

Cognitive function and nigrostriatal markers in abstinent methamphetamine abusers.

@en

P2093

Charles R Schuster

http://www.w3.org/2001/XMLSchema#string

Chris-Ellyn Johanson

http://www.w3.org/2001/XMLSchema#string

Gantt P Galloway

http://www.w3.org/2001/XMLSchema#string

John Roll

http://www.w3.org/2001/XMLSchema#string

Kirk A Frey

http://www.w3.org/2001/XMLSchema#string

Leslie H Lundahl

http://www.w3.org/2001/XMLSchema#string

Michael R Kilbourn

http://www.w3.org/2001/XMLSchema#string

Pamela Keenan

http://www.w3.org/2001/XMLSchema#string

Robert A Koeppe

http://www.w3.org/2001/XMLSchema#string

Trevor Robbins

http://www.w3.org/2001/XMLSchema#string

P2860

Psychoactive substance use disorders in adults with attention deficit hyperactivity disorder (ADHD): effects of ADHD and psychiatric comorbidity.

[3H]methoxytetrabenazine: a high specific activity ligand for estimating monoaminergic neuronal integrity.

Evidence for long-term neurotoxicity associated with methamphetamine abuse: A 1H MRS study

P2888

s00213-006-0330-6

P304

327-338

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00213-006-0330-6

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

185

http://www.w3.org/2001/XMLSchema#string

P50

Nancy A Lockhart

P577

2006-03-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16518646

http://www.w3.org/2001/XMLSchema#string